• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要数字:评估癌症幸存者对个性化和通用统计信息的需求。

Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information.

机构信息

Department of Communication and Cognition, Tilburg Center for Cognition and Communication, Tilburg School of Humanities and Digital Sciences, Tilburg University, P.O. Box 90153, 5037 LE, Tilburg, The Netherlands.

Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

出版信息

BMC Med Inform Decis Mak. 2022 Oct 5;22(1):260. doi: 10.1186/s12911-022-02005-2.

DOI:10.1186/s12911-022-02005-2
PMID:36199092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9535944/
Abstract

BACKGROUND

Statistical information (e.g., on long-term survival or side effects) may be valuable for healthcare providers to share with their patients to facilitate shared decision making on treatment options. In this pre-registered study, we assessed cancer survivors' need for generic (population-based) versus personalized (tailored towards patient/tumor characteristics) statistical information after their diagnosis. We examined how information coping style, subjective numeracy, and anxiety levels of survivors relate to these needs and identified statistical need profiles. Additionally, we qualitatively explored survivors' considerations for (not) wanting statistical information.

METHODS

Cancer survivors' need for statistics regarding incidence, survival, recurrence, side effects and quality of life were assessed with an online questionnaire. For each of these topics, survivors were asked to think back to their first cancer diagnosis and to indicate their need for generic and personalized statistics on a 4-point scale ('not at all'- 'very much'). Associations between information coping style, subjective numeracy, and anxiety with need for generic and personalized statistics were examined with Pearson's correlations. Statistical need profiles were identified using latent class analysis. Considerations for (not) wanting statistics were analyzed qualitatively.

RESULTS

Overall, cancer survivors (n = 174) had a higher need for personalized than for generic statistics (p < .001, d = 0.74). Need for personalized statistics was associated with higher subjective numeracy (r = .29) and an information-seeking coping style (r = .41). Three statistical need profiles were identified (1) a strong need for both generic and personalized statistics (34%), (2) a stronger need for personalized than for generic statistics (55%), and (3) a little need for both generic and personalized statistics (11%). Considerations for wanting personalized cancer statistics ranged from feelings of being in control to making better informed decisions about treatment. Considerations for not wanting statistics related to negative experience with statistics and to the unpredictability of future events for individual patients.

CONCLUSIONS

In light of the increased possibilities for using personalized statistics in clinical practice and decision aids, it appears that most cancer survivors want personalized statistical information during treatment decision-making. Subjective numeracy and information coping style seem important factors influencing this need. We encourage further development and implementation of data-driven personalized decision support technologies in oncological care to support patients in treatment decision making.

摘要

背景

统计信息(例如长期生存或副作用)对于医疗保健提供者与患者共享以促进治疗选择的共同决策可能很有价值。在这项预先注册的研究中,我们评估了癌症幸存者在诊断后对通用(基于人群)与个性化(针对患者/肿瘤特征)统计信息的需求。我们研究了信息应对方式、主观算术能力和幸存者的焦虑水平如何与这些需求相关,并确定了统计需求特征。此外,我们还从定性角度探讨了幸存者对(不)需要统计信息的考虑。

方法

通过在线问卷评估癌症幸存者对发病率、生存率、复发率、副作用和生活质量的统计信息的需求。对于每个主题,幸存者被要求回想他们的第一次癌症诊断,并在 4 分制上表示他们对通用和个性化统计信息的需求(“一点也不”-“非常”)。使用 Pearson 相关分析检查信息应对方式、主观算术能力和焦虑与通用和个性化统计信息需求之间的关联。使用潜在类别分析确定统计需求特征。对(不)想要统计信息的考虑因素进行了定性分析。

结果

总体而言,癌症幸存者(n=174)对个性化统计信息的需求高于通用统计信息(p<0.001,d=0.74)。对个性化统计信息的需求与较高的主观算术能力(r=0.29)和信息寻求应对方式(r=0.41)相关。确定了三种统计需求特征(1)对通用和个性化统计信息都有强烈的需求(34%),(2)对个性化统计信息的需求强于通用统计信息(55%),以及(3)对通用和个性化统计信息的需求都较低(11%)。想要个性化癌症统计信息的考虑因素从控制感到对治疗做出更明智的决策不等。不想要统计信息的考虑因素与对统计信息的负面体验以及对个体患者未来事件的不可预测性有关。

结论

鉴于在临床实践和决策辅助中使用个性化统计信息的可能性增加,大多数癌症幸存者似乎希望在治疗决策制定过程中获得个性化的统计信息。主观算术能力和信息应对方式似乎是影响这种需求的重要因素。我们鼓励进一步开发和实施数据驱动的个性化决策支持技术在肿瘤学护理中,以支持患者的治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/fb873d25f139/12911_2022_2005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/79babb02f420/12911_2022_2005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/385973a897e8/12911_2022_2005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/46cd20600c8c/12911_2022_2005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/fb873d25f139/12911_2022_2005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/79babb02f420/12911_2022_2005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/385973a897e8/12911_2022_2005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/46cd20600c8c/12911_2022_2005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed7/9535944/fb873d25f139/12911_2022_2005_Fig4_HTML.jpg

相似文献

1
Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information.需要数字:评估癌症幸存者对个性化和通用统计信息的需求。
BMC Med Inform Decis Mak. 2022 Oct 5;22(1):260. doi: 10.1186/s12911-022-02005-2.
2
Exploring Cancer Survivor Needs and Preferences for Communicating Personalized Cancer Statistics From Registry Data: Qualitative Multimethod Study.探索癌症幸存者对通过登记数据传达个性化癌症统计信息的需求和偏好:定性多方法研究
JMIR Cancer. 2021 Oct 25;7(4):e25659. doi: 10.2196/25659.
3
Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?传达癌症治疗副作用的个体化风险信息:只有文字还是也有数字?
BMC Med Inform Decis Mak. 2020 Oct 27;20(1):277. doi: 10.1186/s12911-020-01296-7.
4
Patients' and Providers' Needs and Preferences When Considering Fertility Preservation Before Cancer Treatment: Decision-Making Needs Assessment.癌症治疗前考虑生育力保存时患者与医疗服务提供者的需求及偏好:决策需求评估
JMIR Form Res. 2021 Jun 7;5(6):e25083. doi: 10.2196/25083.
5
A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.对所有医疗环境中共同决策的内部和外部影响进行的定性系统评价。
JBI Libr Syst Rev. 2012;10(58):4633-4646. doi: 10.11124/jbisrir-2012-432.
6
Breast Cancer Survivors' Perspectives on Motivational and Personalization Strategies in Mobile App-Based Physical Activity Coaching Interventions: Qualitative Study.基于移动应用的身体活动教练干预中乳腺癌幸存者对动机和个性化策略的观点:定性研究。
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e18867. doi: 10.2196/18867.
7
[Supportive Care and Information Needs of Cancer Survivors: A Comparison of Two Cohorts of Longterm Cancers Survivors 5 and 10 Years after Primary Cancer Diagnosis].[癌症幸存者的支持性护理与信息需求:两组原发性癌症诊断后5年和10年的长期癌症幸存者的比较]
Psychother Psychosom Med Psychol. 2020 Apr;70(3-04):130-137. doi: 10.1055/a-0959-5834. Epub 2019 Aug 29.
8
Physicians' decision-making style and psychosocial outcomes among cancer survivors.癌症幸存者中的医生决策风格与心理社会结局。
Patient Educ Couns. 2009 Dec;77(3):404-12. doi: 10.1016/j.pec.2009.10.004. Epub 2009 Nov 4.
9
Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial.乳腺癌幸存者在参与一项随机对照临床试验七年后对其疾病和治疗的回忆。
BMC Cancer. 2015 Jul 29;15:554. doi: 10.1186/s12885-015-1573-6.
10
Shared decision-making and providing information among newly diagnosed patients with hematological malignancies and their informal caregivers: Not "one-size-fits-all".新诊断血液系统恶性肿瘤患者及其非正式照护者之间的共同决策与信息提供:并非“一刀切”。
Psychooncology. 2017 Dec;26(12):2040-2047. doi: 10.1002/pon.4414. Epub 2017 Apr 17.

引用本文的文献

1
Improving the Implementation of Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative Digital Communication Technologies.改善患者报告结局量表在临床实践中的应用:利用创新数字通信技术应对当前挑战
J Med Internet Res. 2025 Feb 5;27:e60777. doi: 10.2196/60777.
2
DITTO: A Visual Digital Twin for Interventions and Temporal Treatment Outcomes in Head and Neck Cancer.DITTO:头颈癌干预与时间性治疗结果的可视化数字孪生模型
IEEE Trans Vis Comput Graph. 2025 Jan;31(1):65-75. doi: 10.1109/TVCG.2024.3456160. Epub 2024 Nov 25.
3
"R" you getting this? Factors contributing to the public's understanding, evaluation, and use of basic reproduction numbers for infectious diseases.

本文引用的文献

1
Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study.晚期癌症患者不希望了解预后特征的多中心调查研究。
BMC Cancer. 2022 Sep 1;22(1):941. doi: 10.1186/s12885-022-09911-8.
2
Communication, perception, and use of personalized side-effect risks in prostate cancer treatment-decision making: An observational and interview study.沟通、感知和使用前列腺癌治疗决策中的个性化副作用风险:一项观察性和访谈研究。
Patient Educ Couns. 2022 Aug;105(8):2731-2739. doi: 10.1016/j.pec.2022.04.017. Epub 2022 May 4.
3
Comparing Survivors of Cancer in Population-Based Samples With Those in Online Cancer Communities: Cross-sectional Questionnaire Study.
你收到了吗?影响公众对传染病基本繁殖数的理解、评估和使用的因素。
BMC Public Health. 2024 May 1;24(1):1209. doi: 10.1186/s12889-024-18669-6.
4
The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.青少年和年轻成年人(AYAs)中睾丸精原细胞瘤和非精原细胞瘤负担增加:1989 年至 2019 年荷兰的发病率、治疗、疾病特异性生存和死亡率趋势。
ESMO Open. 2024 Feb;9(2):102231. doi: 10.1016/j.esmoop.2023.102231. Epub 2024 Jan 19.
5
Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial).预测工具与沟通技能培训对治疗结果沟通的影响:一项多中心阶梯楔形临床试验(SOURCE试验)
EClinicalMedicine. 2023 Sep 25;64:102244. doi: 10.1016/j.eclinm.2023.102244. eCollection 2023 Oct.
基于人群样本的癌症幸存者与在线癌症社区的癌症幸存者比较:横断面问卷调查研究
JMIR Cancer. 2022 Mar 8;8(1):e19379. doi: 10.2196/19379.
4
Exploring Cancer Survivor Needs and Preferences for Communicating Personalized Cancer Statistics From Registry Data: Qualitative Multimethod Study.探索癌症幸存者对通过登记数据传达个性化癌症统计信息的需求和偏好:定性多方法研究
JMIR Cancer. 2021 Oct 25;7(4):e25659. doi: 10.2196/25659.
5
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.预测前列腺风险沟通工具对新诊断为非转移性前列腺癌男性的临床影响:一项多中心随机对照试验。
Eur Urol. 2021 Nov;80(5):661-669. doi: 10.1016/j.eururo.2021.08.001. Epub 2021 Sep 4.
6
Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer.前列腺切除术后尿失禁的个体风险预测及其对局限性前列腺癌患者治疗选择的影响。
Neurourol Urodyn. 2021 Aug;40(6):1550-1558. doi: 10.1002/nau.24703. Epub 2021 May 18.
7
Communication in decision aids for stage I-III colorectal cancer patients: a systematic review.I-III期结直肠癌患者决策辅助工具中的沟通:一项系统综述。
BMJ Open. 2021 Apr 29;11(4):e044472. doi: 10.1136/bmjopen-2020-044472.
8
Current Best Practice for Presenting Probabilities in Patient Decision Aids: Fundamental Principles.当前患者决策辅助工具中呈现概率的最佳实践:基本原则。
Med Decis Making. 2021 Oct;41(7):821-833. doi: 10.1177/0272989X21996328. Epub 2021 Mar 4.
9
Current Challenges When Using Numbers in Patient Decision Aids: Advanced Concepts.当前患者决策辅助工具中使用数字时面临的挑战:高级概念。
Med Decis Making. 2021 Oct;41(7):834-847. doi: 10.1177/0272989X21996342. Epub 2021 Mar 4.
10
Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?传达癌症治疗副作用的个体化风险信息:只有文字还是也有数字?
BMC Med Inform Decis Mak. 2020 Oct 27;20(1):277. doi: 10.1186/s12911-020-01296-7.